Cargando…

Recent Progress on the Versatility of Virus-Like Particles

Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural proteins of a virus in the absence of genetic material. Having similar morphology to natural viruses but lacking any pathogenicity or infectivity, VLPs have gradually become a safe substitute for inactivated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Ciying, Liu, Xinlin, Xu, Qin, Wang, Zhiping, Chen, Jie, Li, Tingting, Zheng, Qingbing, Yu, Hai, Gu, Ying, Li, Shaowei, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157238/ https://www.ncbi.nlm.nih.gov/pubmed/32244935 http://dx.doi.org/10.3390/vaccines8010139

Ejemplares similares

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
por: Liu, Xinlin, et al.
Publicado: (2019)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

Current progress and challenges in the design and development of a successful COVID-19 vaccine
por: Li, Tingting, et al.
Publicado: (2021)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding
por: He, Maozhou, et al.
Publicado: (2021)

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
por: Li, Zhihai, et al.
Publicado: (2018)

Construction of a bacterial surface display system based on outer membrane protein F
por: Chen, Tingting, et al.
Publicado: (2019)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
por: Li, Zhihai, et al.
Publicado: (2017)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
por: Zhou, Lizhi, et al.
Publicado: (2020)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
por: Zhao, Dongping, et al.
Publicado: (2022)

Structures of pseudorabies virus capsids
por: Wang, Guosong, et al.
Publicado: (2022)

Escherichia coli-derived virus-like particles in vaccine development
por: Huang, Xiaofen, et al.
Publicado: (2017)

Pickering emulsions: Versatility of colloidal particles and recent applications
por: Jiang, Hang, et al.
Publicado: (2020)

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
por: Tissot, Alain C., et al.
Publicado: (2010)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression
por: Zhou, Lizhi, et al.
Publicado: (2022)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice
por: Xue, Wenhui, et al.
Publicado: (2022)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
por: Zhao, Yiwen, et al.
Publicado: (2022)

Structure and proposed DNA delivery mechanism of a marine roseophage
por: Huang, Yang, et al.
Publicado: (2023)

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
por: Ju, Bin, et al.
Publicado: (2022)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
por: Wei, Minxi, et al.
Publicado: (2018)

Recent progress in particle physics
por: De Rújula, Alvaro
Publicado: (1986)

Recent Progress on Two-Dimensional Carbon Materials for Emerging Post-Lithium (Na(+), K(+), Zn(2+)) Hybrid Supercapacitors
por: Han, Chao, et al.
Publicado: (2021)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Phage tail-like particles are versatile bacterial nanomachines – A mini-review
por: Patz, Sascha, et al.
Publicado: (2019)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

Some recent progress in particle detection
por: Charpak, Georges
Publicado: (1972)

Recent progress in the physics of twisted particles
por: Zou, Liping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4a9friqrcsutn1i0e1md5bksab